Viewing StudyNCT01609062



Ignite Creation Date: 2024-05-06 @ 12:33 AM
Last Modification Date: 2024-10-26 @ 10:52 AM
Study NCT ID: NCT01609062
Status: TERMINATED
Last Update Posted: 2016-02-01
First Post: 2012-05-24

Brief Title: Safety and Exercise Study of Two Doses of BMN 110 for Morquio A Syndrome
Sponsor:
Organization: BioMarin Pharmaceutical

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 25
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: